Know Cancer

or
forgot password

Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Cancer

Thank you

Trial Information

Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer


Inclusion Criteria:



- Patients with a diagnosis of malignancy

Exclusion Criteria:

- Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy

Type of Study:

Observational

Study Design:

N/A

Principal Investigator

Chris E Holmes, MD PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Vermont

Authority:

United States: Institutional Review Board

Study ID:

VCC 0806

NCT ID:

NCT01148407

Start Date:

June 2010

Completion Date:

August 2013

Related Keywords:

  • Cancer
  • breast cancer
  • platelets
  • metastatic cancer
  • malignancy

Name

Location

University of Vermont/Fletcher Allen Health CareBurlington, Vermont  05405